Astrazeneca AB v. Apotex Corp., No. 14-1221 (Fed. Cir. Apr. 7, 2015)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Apotex Corp., Apotex Inc., and TorP harm Inc., (collec- tively, “Apotex”) appeal from a final judgment entered against them by the United States District Court for the Southern District of New York. We previously affirmed the district court’s decision in an earlier phase of the same litigation holding that Apotex had infringed certain patents held by Astr aZeneca AB and related parties (collectively, “Astra”). In re Omeprazole Patent Litig., 536 F.3d 1361 (Fed. Cir. 2008).